Perrigo Co. PLC turns a page for the US consumer health products industry as it invests $50m in cannabidiols supplier Kazmira LLC to develop products and help establish quality standards
The deal, which has Perrigo paying $15m upon close and the remainder over 18 months for a 20% stake in Kazmira, marks the first move by a major US manufacturer of OTC drugs into the bourgeoning market for CBD-containing dietary supplements and personal care products